News Blog

color line

Statement from the American Heart Association, the Heart Failure Society of America and the American College of Cardiology

Eduardo Sanchez, M.D., M.P.H., FAAFP, the American Heart Association’s Chief Medical Officer for Prevention, shares advice and resources for patients and others concerned about the coronavirus.

AFib patients face an increased risk of stroke, a potentially devastating event. Now a newer type of blood-thinning medication, non-vitamin K oral anticoagulants, is the preferred alternative to warfarin to reduce the risk of stroke associated with atrial fibrillation.

Please take our survey about your healthcare experience.

Levels of anxiety and depression seen in people who have a common heart rhythm disorder called atrial fibrillation may be affected by how the heart condition is treated, a new study suggests.